Ex vivo radiosensitivity is increased in non-cancer patients taking valproate.

Jenny StritzelbergerJennifer LainerStefanie GollwitzerWolfgang GrafTina JostJohannes D LangTamara M MuellerStefan SchwabRainer FietkauHajo M HamerLuitpold Distel

Published in: BMC neurology (2020)

In our study, we confirmed that patients treated with VPA had an increased radiosensitivity compared to the control group. This could be considered in patients taking VPA prior to the beginning of radiotherapy to avoid toxic side effects of VPA-treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
early stage
peritoneal dialysis
radiation therapy
locally advanced
combination therapy
smoking cessation
patient reported